Eli Lilly broke ground on a $6.5 billion Houston plant that will make Foundayo (orforglipron) and other medicines, creating over 600 jobs as part of its $50 billion push to reshore US drug manufacturing.
Bioweg, backed by €35 million in funding, will build Europe's largest bacterial cellulose plant in Elsdorf, Germany—producing 10,000 tonnes/year of biodegradable, microplastic-free material by 2028.
Milestone completes a $100 million investment cycle in New Jersey and supports Hovione’s long-term vision for a next-generation pharmaceutical development and manufacturing hub.
PharmaBlock Sciences officially inaugurated its new OPC (Oligonucleotides, Peptides, and Conjugates) R&D Center in Nanjing, China.
CordenPharma is investing €80 million at its Caponago, Italy, site, adding a new facility and fill-finish lines to lift sterile injectable capacity to 500 million units/year, backed by shareholder Astorg.
The investment will reinforce the Bend site as a center of excellence for particle engineering and bioavailability enhancement and create a global manufacturing hub for commercial spray-drying.
Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines.
Syensqo is investing in a new compounding line for high-performance aromatic polymers at its Panoli site in India, strengthening its ability to serve customers in one of the world's fastest-growing automotive markets.
AkzoNobel opened a €7.5 million innovation lab at its Sassenheim R&D hub to speed up development of sustainable, solvent-free, energy-efficient powder coatings.
Asahi Kasei opened its new wet-process lithium-ion battery separator coating line in Charlotte, North Carolina. The move supports the company's North American battery separator strategy.
Expansion strengthens integrated manufacture of amorphous solid dispersions (ASDs) by spray drying and tableting at a single site, accelerating development and simplifying supply.
The new Mumbai, India, facility will offer technical testing and application support to diaper and hygiene product customers worldwide.
Production resumes at the Hartlepool facility following LB Group's acquisition, with full capacity targeted by early 2027.
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.
The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.
The project represents a major milestone in the industrial deployment of Catalyxx’s technology and has been recognized as a Project of National Interest (PIN) by the Portuguese Government.
Air Liquide is investing over $160 million to build a new Arizona facility supplying ultra-high-purity gases, including low-carbon hydrogen, to a leading chipmaker's fab expansion, starting operations in 2028.
Syensqo has broken ground on a multi-million-dollar expansion at its Havre de Grace, MD site, boosting capacity by over 30% to meet growing aerospace demand for structural adhesives and surfacing products.
Ineos and Recuro have signed a Memorandum of Understanding to develop a state-of-the-art advanced recycling facility at Ineos’ Bamble polymer site in Norway.
Evonik is modernizing the API production at its Tippecanoe site in the US Over the next five years, the company will invest $100 million in upgrading key plant components.
Berlin start-up company Ucaneo brings industrial-scale carbon removal online just 18 months after groundbreaking.
Covestro is supporting its growth ambitions in the MDI market by building an MDI production facility at its Shanghai site.
IMCD has opened a new Pharmaceutical Technical Centre and Food & Nutrition Hub in Allendale, NJ — bringing labs, co-creation space, and global expertise together to speed up product development.
Dow is pumping $100M into silicones manufacturing across the US, China, and Japan — accelerating supply for EVs, electronics, and medical devices.
Recipharm announced a multi-million-dollar investment in its US operations, strengthening its ability to support pharma and biotech companies with advanced sterile fill and finish services.
Wacker has opened a new silicone production facility in Czechia. After just two years of construction, the first production line in Karlovy Vary was officially put into operation.
€1.5 million grant supports FEED phase of advancing industrial-scale chemical recycling and value chain integration.
Axplora is repositioning its Italian Farmabios site on high-potency APIs as UDCA production moves to its FDA-approved Vizag facility in India, consolidating supply and scaling for global demand.
Röhm's LiMA technology is in full industrial operation in Bay City, Texas (USA).
A clear signal to Berlin: the pharmaceutical companies Eli Lilly and Boehringer Ingelheim are canceling planned investments in Germany.
Sasol is expanding its Brunsbüttel site with a €60 million investment to boost specialty alumina production and strengthen supply for critical catalyst applications. Operations targeted for 2029.
Evonik has opened its first center for beauty science and innovation in Asia at the Evonik Shanghai Innovation Park in China.
Northway Biotech is finalizing the Baltic region's most advanced cell therapy center — a 3,500 m² facility at Vilnius City Innovation Industrial Park, set to open Q3 2025.
Covestro has opened its new thermoplastic polyurethanes (TPU) Application Development (AD) Center in Guangzhou, China.
Piramal Pharma Solutions opens a new payload-linker suite in Michigan as part of a $90 million US investment plan, bolstering its ADC manufacturing capabilities across sites in Riverview and Lexington.
